As a result, methylation of STAT3 by PRMT1 activates STAT3-mediated signaling pathways, leading to the progression and metastasis of several cancers, such as GBM and hepatocellular carcinoma [31,32,33]. This evidence concerns the gene STAT3 and glioblastoma.